[Vital Sign Changes and the Requirement of Analgesics after Discontinuation of Dexmedetomidine in Patients after Esophageal Cancer Surgery.]
There is few study to examine the vital sign changes and the requirement of analgesics after discontinuation of dexmedetomidine in postopera- tive patients. This is a retrospective observational study conducted in 74 patients after esophageal cancer sur- gery. We recorded vital signs including blood pressure, heart rate and respiratory rate one hour before discon- tinuation of dexmedetomidine, and at 1, 2, 4, 6 hours after its discontinuation. We also recorded the use of opioid and analgesic within 6 hours after discontinua- tion. Mean blood pressure, pulse rate, and respi- ratory rate significantly increased after DEX discon- tinuation. Compared with the data before discontinua- tion, the mean blood pressure increased by 13.3 mmHg, heart rate increased by 7.5 beats - min- and respira- tory rate increased by 3.0 times - min-' in average at 6 hours after discontinuation. There were 28 patients (38%) who required the additional analgesics within 6 hours after discontinuation. After discontinuation of dexmedetomi- dine, significant changes of vital signs, especially in mean blood pressure, were observed in post-esopha- gectomy patients. About 38% of them required addi- tional analgesics within 6 hours after dexmedetomidine discontinuation.